search
Back to results

Ketone Esters for Optimization of Cognitive Performance in Hypoxia

Primary Purpose

Hypoxia, Ketosis

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ketone Ester
Taste Matched Placebo
Hypoxic exposure
Sponsored by
HVMN Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hypoxia

Eligibility Criteria

18 Years - 45 Years (Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

* Pass medical examination on enrollment.

Exclusion Criteria:

* Active smoker, substance abuse.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm Type

    Placebo Comparator

    Placebo Comparator

    Experimental

    Experimental

    Arm Label

    Placebo + Normoxia

    Placebo + Hypoxia

    Ketone Ester + Normoxia

    Ketone Ester + Hypoxia

    Arm Description

    Taste, volume and appearance matched drink given before cognitive testing in normoxia

    Taste, volume and appearance matched drink given before cognitive testing in hypoxia

    Ketone ester drink given before cognitive testing in normoxia

    Ketone ester drink given before cognitive testing in hypoxia

    Outcomes

    Primary Outcome Measures

    Change in Cognitive Performance- Visual Acuity
    Cognitive performance (visual acuity) will be assessed using the RightEye testing system (https://www.righteye.com).
    Change in Cognitive Performance- Contrast Sensitivity
    Cognitive performance (contrast sensitivity) will be assessed using the RightEye testing system (https://www.righteye.com).
    Change in Cognitive Performance- Choice Reaction Time
    Cognitive performance (choice reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).
    Change in Cognitive Performance- Eye Tracking- Smooth Pursuit
    Cognitive performance (eye tracking) will be assessed by looking for smooth pursuit (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).
    Change in Cognitive Performance- Eye Tracking- Saccades
    Cognitive performance (eye tracking) will be assessed by looking at saccade speed (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).
    Change in Cognitive Performance- Simple Reaction Time
    Cognitive performance (simple reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).

    Secondary Outcome Measures

    Change in Grip Strength
    Grip strength will be measured using a
    Change in blood ketone levels
    Blood ketone levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).
    Change in blood glucose levels
    Blood glucose levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).

    Full Information

    First Posted
    August 14, 2018
    Last Updated
    September 5, 2018
    Sponsor
    HVMN Inc
    Collaborators
    Florida Institute for Human and Machine Cognition
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03659825
    Brief Title
    Ketone Esters for Optimization of Cognitive Performance in Hypoxia
    Official Title
    Ketone Esters for Optimization of Cognitive Performance in Hypoxia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2018
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 1, 2018 (Anticipated)
    Primary Completion Date
    October 31, 2018 (Anticipated)
    Study Completion Date
    November 15, 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    HVMN Inc
    Collaborators
    Florida Institute for Human and Machine Cognition

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study will investigate the effects of ketone ester drinks on cognitive performance in hypoxia.
    Detailed Description
    In the setting of altitude-induced hypoxia, cognitive capacity degrades and can compromise both individual and team performance. This degradation is linked to falling brain energy (ATP) levels and an increased reliance on anaerobic energy production from glucose. Ketone bodies are the evolutionary alternative substrate to glucose for brain metabolic requirements; previous studies have shown that the presence of elevated ketone bodies (ketosis) maintains brain ATP levels and reduce cerebral anaerobic glycolysis during hypoxia. Ketosis can be achieved when fasting or following a ketogenic diet; however, these approaches are impractical. Exogenous ketone ester supplementation allows for rapid (< 30 mins) and significant elevation of blood ketone levels without the need to maintain a diet or fast. HVMN, in collaboration with researchers at IHMC, proposes a study to investigate the effects of consuming an FDA-approved ketone ester 'food' on cognitive performance in the setting of hypoxia. For the proposed 4-arm within-subject study, participants will complete a cognitive performance test battery under the conditions of normoxia and then hypoxia following consumption of a ketone ester drink or a placebo drink (N.B for each study drink cognitive performance in both hypoxia and normoxia will be assessed in ONE visit): VISIT A: Arm1: Normoxia + Placebo Arm 2: Hypoxia + Placebo VISIT B: Arm 3: Normoxia + Ketone ester Arm 4: Hypoxia + Ketone ester The investigators hypothesize that ketone ester supplementation will attenuate hypoxia-induced deterioration of operator cognitive performance.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Hypoxia, Ketosis

    7. Study Design

    Primary Purpose
    Basic Science
    Study Phase
    Not Applicable
    Interventional Study Model
    Crossover Assignment
    Model Description
    Young healthy adults.
    Masking
    ParticipantInvestigator
    Masking Description
    Study drinks will be matched for taste and appearance. Investigator preparing and administering the drink will not carry out the testing.
    Allocation
    Randomized
    Enrollment
    16 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Placebo + Normoxia
    Arm Type
    Placebo Comparator
    Arm Description
    Taste, volume and appearance matched drink given before cognitive testing in normoxia
    Arm Title
    Placebo + Hypoxia
    Arm Type
    Placebo Comparator
    Arm Description
    Taste, volume and appearance matched drink given before cognitive testing in hypoxia
    Arm Title
    Ketone Ester + Normoxia
    Arm Type
    Experimental
    Arm Description
    Ketone ester drink given before cognitive testing in normoxia
    Arm Title
    Ketone Ester + Hypoxia
    Arm Type
    Experimental
    Arm Description
    Ketone ester drink given before cognitive testing in hypoxia
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Ketone Ester
    Other Intervention Name(s)
    HVMN Ketone
    Intervention Description
    Flavored sports drink containing deltaG (betahydroxybutyrate monoester) as the sole active ingredient, diluted with water.
    Intervention Type
    Dietary Supplement
    Intervention Name(s)
    Taste Matched Placebo
    Intervention Description
    Placebo that tastes similar to active intervention
    Intervention Type
    Other
    Intervention Name(s)
    Hypoxic exposure
    Intervention Description
    Participants will breath through a mask to provide the amount of oxygen typically seen at 16-17,000ft of altitude.
    Primary Outcome Measure Information:
    Title
    Change in Cognitive Performance- Visual Acuity
    Description
    Cognitive performance (visual acuity) will be assessed using the RightEye testing system (https://www.righteye.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Title
    Change in Cognitive Performance- Contrast Sensitivity
    Description
    Cognitive performance (contrast sensitivity) will be assessed using the RightEye testing system (https://www.righteye.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Title
    Change in Cognitive Performance- Choice Reaction Time
    Description
    Cognitive performance (choice reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Title
    Change in Cognitive Performance- Eye Tracking- Smooth Pursuit
    Description
    Cognitive performance (eye tracking) will be assessed by looking for smooth pursuit (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Title
    Change in Cognitive Performance- Eye Tracking- Saccades
    Description
    Cognitive performance (eye tracking) will be assessed by looking at saccade speed (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Title
    Change in Cognitive Performance- Simple Reaction Time
    Description
    Cognitive performance (simple reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).
    Time Frame
    Measured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.
    Secondary Outcome Measure Information:
    Title
    Change in Grip Strength
    Description
    Grip strength will be measured using a
    Time Frame
    Measured 3 times (baseline [time = 0 min], after normoxia [60 min post study drink 1] and after hypoxia [60 min post study drink 2]) in each of the two test visits.
    Title
    Change in blood ketone levels
    Description
    Blood ketone levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).
    Time Frame
    Measured 5 times at regular intervals through each of the two study visits. [time (min) = 0, 30, 75, 105, 150]
    Title
    Change in blood glucose levels
    Description
    Blood glucose levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).
    Time Frame
    Measured 5 times at regular intervals through each of the two study visits. [time (min) = 0, 30, 75, 105, 150]

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    45 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: * Pass medical examination on enrollment. Exclusion Criteria: * Active smoker, substance abuse.

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    Citations:
    PubMed Identifier
    29163194
    Citation
    Stubbs BJ, Cox PJ, Evans RD, Santer P, Miller JJ, Faull OK, Magor-Elliott S, Hiyama S, Stirling M, Clarke K. On the Metabolism of Exogenous Ketones in Humans. Front Physiol. 2017 Oct 30;8:848. doi: 10.3389/fphys.2017.00848. eCollection 2017.
    Results Reference
    background
    PubMed Identifier
    11700013
    Citation
    Suzuki M, Suzuki M, Sato K, Dohi S, Sato T, Matsuura A, Hiraide A. Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn J Pharmacol. 2001 Oct;87(2):143-50. doi: 10.1254/jjp.87.143.
    Results Reference
    background
    PubMed Identifier
    6775394
    Citation
    Kirsch JR, D'Alecy LG, Mongroo PB. Butanediol induced ketosis increases tolerance to hypoxia in the mouse. Stroke. 1980 Sep-Oct;11(5):506-13. doi: 10.1161/01.str.11.5.506.
    Results Reference
    background
    PubMed Identifier
    20204773
    Citation
    Xu K, Sun X, Eroku BO, Tsipis CP, Puchowicz MA, LaManna JC. Diet-induced ketosis improves cognitive performance in aged rats. Adv Exp Med Biol. 2010;662:71-5. doi: 10.1007/978-1-4419-1241-1_9.
    Results Reference
    background
    Links:
    URL
    https://hvmn.com
    Description
    HVMN product website

    Learn more about this trial

    Ketone Esters for Optimization of Cognitive Performance in Hypoxia

    We'll reach out to this number within 24 hrs